Skip to main content
SpringerLink
Log in
Book cover

Head and Neck Cancer pp 591–606Cite as

Multidisciplinary Treatment of the Neck

  • Chapter
  • First Online:

  • 2401 Accesses

Abstract

Since lymph node metastases are one of the most important prognostic factors, treatment of the neck is challenging. In clinically N0 neck, (super)selective neck dissection is indicated, whereas a more extensive neck dissection with preservation of important structures is performed in N2–N3 disease. Adjuvant treatment consists of radiotherapy with or without chemotherapy in patients with an intermediate or high risk of recurrence in the neck. Primary radiotherapy alone is effective in non-bulky disease. In more extensive neck disease, a combination of radiotherapy and chemotherapy with or without planned neck dissection is indicated. Advances in imaging and treatment as well as risk assessment have further modified the paradigm of planned neck dissection. Primary chemoradiation is effective for sterilising occult disease, and, therefore, post-treatment (super)selective neck dissection seems to be sufficient.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   219.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Rouvière H. Anatomie des lymphatiques de l’homme. Paris: Masson et Cie; 1932.

    Google Scholar 

  2. Robbins KT, Medina JE, Wolfe GT, et al. Standardizing neck dissection terminology. Official report of the Academy’s Committee for head and neck surgery and oncology. Arch Otolaryngol Head Neck Surg. 1991;117:601–5.

    Article  CAS  PubMed  Google Scholar 

  3. Grégoire V, Levendag P, Ang KK, et al. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol. 2003;69:227–36.

    Article  PubMed  Google Scholar 

  4. Sobin LH, Wittekind C, editors. TNM classification of malignant tumours. 6th ed. New York, NY: Wiley-Liss; 2002.

    Google Scholar 

  5. Brown KM, Lango M, Ridge JA. The role of neck dissection in the combined modality therapy setting. Semin Oncol. 2008;35:229–35.

    Article  PubMed  Google Scholar 

  6. Smeele LE, Leemans CR, Reid CBA, et al. Neck dissection for advanced lymph node metastasis before definitive radiotherapy for primary carcinoma of the head and neck. Laryngoscope. 2000;110:2110–1214.

    Article  Google Scholar 

  7. Wang SJ, Wang MB, Calcaterra TC. Radiotherapy followed by neck dissection for small head and neck cancer with advanced cervical metastases. Ann Otol Rhinol Laryngol. 1999;108:128–31.

    Article  CAS  PubMed  Google Scholar 

  8. Crile GW. Excision of cancer in the head and neck. With special reference to the plan of dissection based on one hundred and thirty-two operations. JAMA. 1906;47:1780–6.

    Article  Google Scholar 

  9. Robbins KT, Clayman G, Levine PA, et al. Neck dissection classification update. Revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery. Arch Otolaryngol Head Neck Surg. 2002;128:751–8.

    Article  PubMed  Google Scholar 

  10. Paleri V, Kumar Subramaniam S, Ozeer N, et al. Dissection of the submuscular recess (sublevel IIb) in squamous cell carcinoma of the upper aerodigestive tract: prospective study and review of the literature. Head Neck. 2008;30:194–200.

    Article  PubMed  Google Scholar 

  11. Jia S, Wang Y, He H, Xiang C. Incidence of level IIB lymph node metastasis in supraglottic laryngeal squamous cell carcinoma with clinically negative neck—a prospective study. Head Neck. 2013;35:987–91.

    Article  PubMed  Google Scholar 

  12. Redaelli de Zinis LO, Nicolai P, Tomenzoli D, et al. The distribution of lymph node metastases in supraglottic squamous cell carcinoma: therapeutic implications. Head Neck. 2002;24:913–20.

    Article  PubMed  Google Scholar 

  13. Werner JA. Selective sentinel lymphadenectomy for head and neck squamous cell carcinoma. Cancer Treat Res. 2005;127:187–206.

    Article  PubMed  Google Scholar 

  14. Balm AJ, Brown DH, De Vries WA, et al. Blindness: a potential complication of bilateral neck dissection. J Laryngol Otol. 1990;104:154–6.

    Article  CAS  PubMed  Google Scholar 

  15. Snyderman CH, D’Amico F. Outcome of carotid artery resection for neoplastic disease: a meta-analysis. Am J Otolaryngol. 1992;13:373–80.

    Article  CAS  PubMed  Google Scholar 

  16. Yu Q, Wang P, Shi H, et al. Carotid artery and jugular vein invasion of oralmaxillofacial and neck malignant tumors: diagnostic value of computed tomography. Oral Surg Oral Med Oral Pathol Oral Radiol Endo. 2003;96:368–72.

    Article  Google Scholar 

  17. Yousem DM, Hatabu H, Hurst RW, et al. Carotid artery invasion by head and neck masses: prediction with MR imaging. Radiology. 1995;195:715–20.

    Article  CAS  PubMed  Google Scholar 

  18. Lodder WL, Lange CA, Teertstra HJ, et al. Value of MR and CT imaging for assessment of internal carotid artery encasement in head and neck squamous cell carcinoma. Int J Surg Oncol. Epub 2013 Jan 29

    Google Scholar 

  19. Weber R, Marvel J, Smith P, et al. Paratracheal lymph node dissection for carcinoma of the larynx, hypopharynx and cervical oesophagus. Otolaryngol Head Neck Surg. 1993;108:11–7.

    Article  CAS  PubMed  Google Scholar 

  20. Leon X, Quer M, Burgues J, et al. Prevention of stomal recurrence. Head Neck. 1996;18:54–9.

    Article  CAS  PubMed  Google Scholar 

  21. Plaat RE, de Bree R, Kuik DJ, et al. Prognostic importance of paratracheal lymph node metastases. Laryngoscope. 2005;115:894–8.

    Article  PubMed  Google Scholar 

  22. Timon CV, Toner M, Conlon BJ. Paratracheal lymph node involvement in advanced cancer of the larynx, hypopharynx, and cervical esophagus. Laryngoscope. 2003;113:1595–9.

    Article  PubMed  Google Scholar 

  23. Petrovic Z, Djordjevic V. Stomal recurrence after primary total laryngectomy. Clin Otolaryngol. 2004;29:270–3.

    Article  CAS  PubMed  Google Scholar 

  24. De Bree R, Leemans CR, Silver CE. Paratracheal lymph node dissection in cancer of the larynx, hypopharynx, and cervical esophagus: the need for guidelines. Head Neck. 2011;33:912–6.

    Article  PubMed  Google Scholar 

  25. Leemans CR, Tiwari R, van der Waal I, et al. The efficacy of comprehensive neck dissection with or without postoperative radiotherapy in nodal metastases of squamous cell carcinoma of the upper respiratory and digestive tracts. Laryngoscope. 1990;100:1194–8.

    Article  CAS  PubMed  Google Scholar 

  26. Huang DT, Johnson CR, Schmidt-Ulrich R, et al. Postoperative radiotherapy in head and neck carcinoma with extracapsular lymph node extension and/or positive margins: a comparative study. Int J Radiat Oncol Biol Phys. 1992;23:737–42.

    Article  CAS  PubMed  Google Scholar 

  27. Bartelink H, Breur K, Hart G, et al. The value of postoperative radiotherapy as an adjuvant to radical neck dissection. Cancer. 1983;52:1008–13.

    Article  CAS  PubMed  Google Scholar 

  28. Nisi KW, Foote RL, Bonner JA, et al. Adjuvant radiotherapy for squamous cell carcinoma of the tongue base: improved local-regional disease control compared with surgery alone. Int J Radiat Oncol Biol Phys. 1998;41:371–7.

    Article  CAS  PubMed  Google Scholar 

  29. Franceschi D, Gupta R, Spiro RH, et al. Improved survival in the treatment of squamous carcinoma of the oral tongue. Am J Surg. 1993;166:360–5.

    Article  CAS  PubMed  Google Scholar 

  30. Lundahl RE, Foote RL, Bonner JA, et al. Combined neck dissection and postoperative radiation therapy in the management of the high-risk neck: a matched-pair analysis. Int J Radiat Oncol Biol Phys. 1998;40:529–34.

    Article  CAS  PubMed  Google Scholar 

  31. Frank JL, Garb JL, Kay S, et al. Postoperative radiotherapy improves survival in squamous cell carcinoma of the hypopharynx. Am J Surg. 1994;168:476–80.

    Article  CAS  PubMed  Google Scholar 

  32. Huang D, Johnson CR, Schmidt-Ullrich RK, et al. Incompletely resected advanced squamous cell carcinoma of the head and neck: the effectiveness of adjuvant vs. salvage radiotherapy. Radiother Oncol. 1992;24:87–93.

    Article  CAS  PubMed  Google Scholar 

  33. Strojan P, Ferlito A, Langendijk JA, et al. Indications for radiotherapy after neck dissection. Head Neck. 2012;34:113–9.

    Article  PubMed  Google Scholar 

  34. Langendijk JA, Slotman BJ, van der Waal I, et al. Risk-group definition by recursive partitioning analysis of patients with squamous cell carcinoma treated with surgery and postoperative radiotherapy. Cancer. 2005;104:1408–17.

    Article  PubMed  Google Scholar 

  35. Jonkman A, Kaanders JHAM, Terhaard CHJ, et al. Multicenter validation of recursive partitioning analysis classification for patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy. Int J Radiat Oncol Biol Phys. 2007;68:119–25.

    Article  PubMed  Google Scholar 

  36. Leon X, Lopez M, Pineiro Z, et al. External validation of a risk group defined by recursive partitioning analysis in patients with head and neck carcinoma treated with surgery and postoperative radiotherapy. Head Neck. 2007;29:815–21.

    Article  PubMed  Google Scholar 

  37. Bernier J, Domenge C, Ozsahin M, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med. 2004;350:1945–52.

    Article  CAS  PubMed  Google Scholar 

  38. Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med. 2004;350:1937–44.

    Article  PubMed  Google Scholar 

  39. Cooper JS, Zhang Q, Pajak TF, et al. Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 2012;84:1198–205.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Bernier J, Cooper JS, Pajak TF, et al. Ding risk levels in locally advanced head and neck cancers. A comparative analysis of concurrent postoperative radiation and chemotherapy trials of the EORTC (#22931) and RTOG (#9501). Head Neck. 2005;27:843–50.

    Article  PubMed  Google Scholar 

  41. Ang KK, Trotti A, Brown BW, et al. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head and neck cancer. Int J Radiat Oncol Biol Phys. 2001;51:571–8.

    Article  CAS  PubMed  Google Scholar 

  42. Awwad HK, Lotayef M, Shouman T, et al. Accelerated hyperfractionation (AHF) compared to conventional fractionation (CF) in the postoperative radiotherapy of locally advanced head and neck cancer: influence of proliferation. Br J Cancer. 2002;86:517–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Bastit L, Blot E, Debourdeau P, et al. Influence of the delay of adjuvant postoperative radiation therapy on relapse and survival in oropharyngeal and hypopharyngeal cancers. Int J Radiat Oncol Biol Phys. 2001;49:139–46.

    Article  CAS  PubMed  Google Scholar 

  44. Muriel VP, Tejada MR, de Dios Luna del Castillo J. Time-dose-response relationships in postoperatively irradiated patients with head and neck squamous cell carcinomas. Radiother Oncol. 2001;60:137–45.

    Article  CAS  PubMed  Google Scholar 

  45. Parsons JT, Mendenhall WM, Stringer SP, et al. An analysis of factors influencing the outcome of postoperative irradiation for squamous cell carcinoma of the oral cavity. Int J Radiat Oncol Biol Phys. 1997;39:137–48.

    Article  CAS  PubMed  Google Scholar 

  46. Schiff PB, Harrison LB, Strong EW, et al. Impact of the time interval between surgery and postoperative radiation therapy on locoregional control in advanced head and neck cancer. J Surg Oncol. 1990;43:203–8.

    Article  CAS  PubMed  Google Scholar 

  47. Strojan P, Beitler JJ, Silver CE, et al. When is re-irradiation in head and neck squamous cell carcinoma not indicated? Eur Arch Otorhinolaryngol. 2014;271:3107–9.

    Article  PubMed  Google Scholar 

  48. Vergeer MR, Doornaert P, Leemans CR, et al. Control of nodal metastases in squamous head and neck cancer treated by radiation therapy or chemoradiation. Radiother Oncol. 2006;79:39–44.

    Article  PubMed  Google Scholar 

  49. Vergeer MR, Doornaert PA, de Bree R, et al. Postoperative elective nodal irradiation for squamous cell carcinoma of the head and neck: outcome and prognostic factors for regional recurrence. Ann Oncol. 2011;22:2489–94.

    Article  CAS  PubMed  Google Scholar 

  50. Hermans R, op de Beeck K, van den Bogaert W, et al. The relation of CT-determined tumor parameters and local and regional outcome of tonsillar cancer after definitive radiation treatment. Int J Radiat Oncol Biol Phys. 2001;50:37–45.

    Article  CAS  PubMed  Google Scholar 

  51. Ballonoff A, Raben D, Rusthoven KE, et al. Outcome of patients with N3 neck nodes treated with chemoradiation. Laryngoscope. 2008;118:995–8.

    Article  PubMed  Google Scholar 

  52. Overgaard J, Hansen HS, Specht L, et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet. 2003;362:933–40.

    Article  PubMed  Google Scholar 

  53. Karakaya E, Yetmen O, Oksuz DC, et al. Outcomes following chemoradiotherapy for N3 head and neck squamous cell carcinoma without a planned neck dissection. Oral Oncol. 2013;49:55–9.

    Article  PubMed  Google Scholar 

  54. Igidbashian L, Fortin B, Guertin L, et al. Outcome with neck dissection after chemoradiation for N3 head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2010;77:414–20.

    Article  PubMed  Google Scholar 

  55. Strojan P, Ferlito A, Langendijk JA, et al. Contemporary management of lymph node metastases from an unknown primary to the neck: II. A review of therapeutic options. Head Neck. 2013;35:286–93.

    Article  PubMed  Google Scholar 

  56. McHam SA, Adelstein DJ, Rybicki LA, et al. Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer? Head Neck. 2003;25:791–8.

    Article  PubMed  Google Scholar 

  57. Kutler DI, Patel SG, Shah JP. The role of neck dissection following definitive chemoradiation. Oncology. 2004;18:993–8.

    PubMed  Google Scholar 

  58. Mukherji SK, Wolf GT. Evaluation of head and neck squamous cell carcinoma after treatment. AJNR Am J Neuroradiol. 2003;24:1743–6.

    PubMed  Google Scholar 

  59. Farrag TY, Lin FR, Cummings CW, et al. Neck management in patients undergoing postradiotherapy salvage laryngeal surgery for recurrent/persistent laryngeal cancer. Laryngoscope. 2006;116:1864–6.

    Article  PubMed  Google Scholar 

  60. Liauw SL, Mancuso AA, Amdur RJ, et al. Postradiotherapy neck dissection for lymph node-positive head and neck cancer: the use of computed tomography to manage the neck. J Clin Oncol. 2006;24:1421–7.

    Article  PubMed  Google Scholar 

  61. Ojiri H, Mendenhall WM, Stringer SP, et al. Post-RT CT results as a predictive model for the necessity of planned post-RT neck dissection in patients with cervical metastatic disease from squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2002;52:420–8.

    Article  PubMed  Google Scholar 

  62. Vedrine PO, Thariat J, Hitier M, et al. Need for neck dissection after radiochemotherapy? A study of the French GETTEC Group. Laryngoscope. 2008;118:1775–80.

    Article  PubMed  Google Scholar 

  63. de Bree R, van der Putten L, Brouwer J, et al. Detection of locoregional recurrent head and neck cancer after (chemo)radiotherapy using modern imaging. Oral Oncol. 2009;45:386–93.

    Article  PubMed  Google Scholar 

  64. Rogers JW, Greven KM, McGuirt WF, et al. Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy? Int J Radiat Oncol Biol Phys. 2004;58:694–7.

    Article  PubMed  Google Scholar 

  65. McCollum AD, Burrell SC, Haddad RI, et al. Positron emission tomography with 18F-fluorodeoxyglucose to predict pathologic response after induction chemotherapy and definitive chemoradiotherapy in head and neck cancer. Head Neck. 2004;26:890–6.

    Article  PubMed  Google Scholar 

  66. Brkovich VS, Miller FR, Karnad AB, et al. The role of positron emission tomography scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy. Laryngoscope. 2006;116:855–8.

    Article  PubMed  Google Scholar 

  67. Kao J, Vu HL, Genden EM, et al. The diagnostic and prognostic utility of positron emission tomography/computed tomography-based follow-up after radiotherapy for head and neck cancer. Cancer. 2009;115:4586–94.

    Article  PubMed  Google Scholar 

  68. Porceddu SV, Jarmolowski E, Hicks RJ, et al. Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer. Head Neck. 2005;27:175–81.

    Article  PubMed  Google Scholar 

  69. Yao M, Smith RB, Graham MM, et al. The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment. Int J Radiat Oncol Biol Phys. 2005;63:991–9.

    Article  PubMed  Google Scholar 

  70. Loo SW, Geropantas K, Beadsmoore C, et al. Neck dissection can be avoided after sequential chemoradiotherapy and negative post-treatment positron emission tomography-computed tomography in N2 head and neck squamous cell carcinoma. Clin Oncol. 2011;23:512–7.

    Article  CAS  Google Scholar 

  71. Nayak JY, Walvekar R, Andrade RS, et al. Deferring planned neck dissection following chemoradiation for stage IV head and neck cancer: the utility of PET-CT. Laryngoscope. 2007;117:2129–34.

    Article  PubMed  Google Scholar 

  72. Moeller BJ, Rana V, Cannon BA, et al. Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer. J Clin Oncol. 2009;27:2509–15.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Isles MG, McConkey C, Mehanna HM. A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy. Clin Otolaryngol. 2008;33:210–22.

    Article  CAS  PubMed  Google Scholar 

  74. Vandecaveye V, de Keyzer F, Nuyts S, et al. Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radiotherapy: correlation between radiologic and histopathologic findings. Int J Radiat Oncol Biol Phys. 2007;67:960–71.

    Article  PubMed  Google Scholar 

  75. King AD, Mo FK, Yu KH, et al. Squamous cell carcinoma of the head and neck: diffusion-weighted MR imaging for prediction and monitoring of treatment response. Eur Radiol. 2010;20:2213–20.

    Article  PubMed  Google Scholar 

  76. Schouten CS, de Graaf P, Alberts FM, et al. Response evaluation after chemoradiotherapy for advanced nodal disease in head and neck cancer using diffusion-weighted MRI and 18F-FDG-PET-CT. Oral Oncol. 2015;51(5):541–7.

    Article  PubMed  Google Scholar 

  77. Frank DK, Hu KS, Culliney BE, et al. Planned neck dissection after concomitant radiochemotherapy for advanced head and neck cancer. Laryngoscope. 2005;115:1015–20.

    Article  PubMed  Google Scholar 

  78. Sewall GK, Palazzi-Churas KL, Richards GM, et al. Planned postradiotherapy neck dissection: rationale and clinical outcomes. Laryngoscope. 2007;117:121–8.

    Article  PubMed  Google Scholar 

  79. Narayan K, Crane CH, Kleid S, et al. Planned neck dissection as an adjunct to the management of patients with advanced neck disease treated with definitive radiotherapy: for some or for all? Head Neck. 1999;21:606–13.

    Article  CAS  PubMed  Google Scholar 

  80. Weisman RA, Robbins KT. Management of the neck in patients with head and neck cancer treated by concurrent chemotherapy and radiation. Otolaryngol Clin North Am. 1998;31:773–84.

    Article  CAS  PubMed  Google Scholar 

  81. Robbins KT, Wong FS, Kumar P, et al. Efficacy of targeted chemoradiation and planned selective neck dissection to control bulky nodal disease in advanced head and neck cancer. Arch Otolaryngol Head Neck Surg. 1999;125:670–5.

    Article  CAS  PubMed  Google Scholar 

  82. Corry J, Smith JG, Peters LJ. The concept of a planned neck dissection is obsolete. Cancer J. 2001;7:472–4.

    CAS  PubMed  Google Scholar 

  83. Pellitteri PK, Ferlito A, Rinaldo A, et al. Planned neck dissection following chemoradiotherapy for advanced head and neck cancer: is it necessary for all? Head Neck. 2006;28:166–75.

    Article  PubMed  Google Scholar 

  84. Grabenbauer GG, Rodel C, Ernst-Stecken A, et al. Neck dissection following radiochemotherapy of advanced head and neck cancer—for selected cases only? Radiother Oncol. 2003;66:57–63.

    Article  PubMed  Google Scholar 

  85. Gokhale AS, Lavertu P. Surgical salvage after chemoradiation of head and neck cancer: complications and outcomes. Curr Oncol Rep. 2001;3:72–6.

    Article  CAS  PubMed  Google Scholar 

  86. Agra IM, Carvalho AL, Pontes E, et al. Postoperative complications after en bloc salvage surgery for head and neck cancer. Arch Otolaryngol Head Neck Surg. 2003;129:1317–21.

    Article  PubMed  Google Scholar 

  87. Mendenhall WM, Million RR, Cassisi NJ. Squamous cell carcinoma treated with radiation therapy: the role of neck dissection for clinically positive neck nodes. Int J Radiat Oncol Biol Phys. 1986;12:733–40.

    Article  CAS  PubMed  Google Scholar 

  88. Lavertu P, Adelstein DJ, Saxton JP, et al. Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell carcinoma head and neck cancer. Head Neck. 1997;19:559–66.

    Article  CAS  PubMed  Google Scholar 

  89. Clayman GL, Johnson II CJ, Morrison W, et al. The role of neck dissection after chemoradiotherapy for oropharyngeal cancer with advanced nodal disease. Arch Otolaryngol Head Neck Surg. 2001;127:135–9.

    Article  CAS  PubMed  Google Scholar 

  90. Argiris A, Stenson KM, Brockstein BE, et al. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer. Head Neck. 2004;26:447–55.

    Article  PubMed  Google Scholar 

  91. Goguen LA, Posner MR, Tishler RB, et al. Examining the need for neck dissection in the era of chemoradiation therapy for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg. 2006;132:526–31.

    Article  PubMed  Google Scholar 

  92. Sanguineti G, Corvo R, Benasso M, et al. Management of the neck after alternating chemoradiotherapy for advanced head and neck cancer. Head Neck. 1999;21:223–8.

    Article  CAS  PubMed  Google Scholar 

  93. Wolf GT, Fisher SG. Effectiveness of salvage neck dissection for advanced regional metastases when induction chemotherapy and radiation are used for organ preservation. Laryngoscope. 1992;102:934–9.

    Article  CAS  PubMed  Google Scholar 

  94. Ojiri H, Mancuso AA, Mendenhall WM, et al. Lymph nodes of patients with regional metastases from head and neck squamous cell carcinoma as a predictor of pathologic outcome: size changes at CT before and after radiation therapy. AJNR Am J Neuroradiol. 2002;23:1627–31.

    PubMed  Google Scholar 

  95. van der Putten L, van den Broek GB, de Bree R, et al. Effectiveness of salvage selective and modified radical neck dissection for regional pathological lymphadenopathy after chemoradiation. Head Neck. 2009;31:593–603.

    Article  PubMed  Google Scholar 

  96. Soltys SG, Choi CY, Fee WE, et al. A planned neck dissection is not necessary in all patients with N2-3 head-and-neck cancer after sequential chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2012;83:994–9.

    Article  PubMed  Google Scholar 

  97. Thariat J, Ang KK, Allen PK, et al. Prediction of neck dissection requirement after definitive radiotherapy for head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2012;82:e367–374.

    Article  PubMed  PubMed Central  Google Scholar 

  98. Prendes BL, Aubin-Pouliot A, Egbert N, et al. Elective lymphadenectomy during salvage for locally recurrent head and neck squamous cell carcinoma after radiation. Arch Otolaryngol Head Neck Surg. 2014;151:462–7.

    Article  Google Scholar 

  99. Wei WI. Salvage neck dissection after radiation and/or chemotherapy. Operative Techniques Otolaryngol. 2004;15:269–72.

    Article  Google Scholar 

  100. Robbins KT, Doweck I, Samant S, Vieira F. Effectiveness of superselective and selective neck dissection for advanced nodal metastases after chemoradiation. Arch Otolaryngol Head Neck Surg. 2005;131:965–9.

    Article  PubMed  Google Scholar 

  101. Stenson KM, Huo D, Blair E, Cohen EE, Argiris A, Haraf DJ, et al. Planned post-chemoradiation neck dissection: significance of radiation dose. Laryngoscope. 2006;116:33–6.

    Article  PubMed  Google Scholar 

  102. Mukhija V, Gupta S, Jacobson AS, et al. Selective neck dissection following adjuvant therapy for advanced head and neck cancer. Head Neck. 2009;31:183–8.

    Article  PubMed  Google Scholar 

  103. Robbins KT, Dhiwakar M, Vieira F, et al. Efficacy of super-selective neck dissection following chemoradiation for advanced head and neck cancer. Oral Oncol. 2012;48:1185–9.

    Article  PubMed  Google Scholar 

  104. Goguen LA, Chapuy CI, Sher DJ, et al. Utilizing computed tomography as a road map for designing selective and superselective neck dissection after chemoradiotherapy. Otolaryngol Head Neck Surg. 2010;143:367–74.

    Article  PubMed  Google Scholar 

  105. Dias FL, Kligerman J, de Matos S, et al. Elective neck dissection versus observation in stage I squamous cell carcinoma of the tongue and floor of mouth. Otolaryngol Head Neck Surg. 2001;125:23–9.

    Article  CAS  PubMed  Google Scholar 

  106. Capote A, Escorial V, Muňoz-Guerra MF, et al. Elective neck dissection in early-stage oral squamous cell carcinoma – does it influence recurrence and survival? Head Neck. 2007;29:3–11.

    Article  PubMed  Google Scholar 

  107. Yuen APW, Wei WI, Wong YM, et al. Elective neck dissection versus observation in the treatment of early oral tongue carcinoma. Head Neck. 1997;19:583–8.

    Article  CAS  PubMed  Google Scholar 

  108. Yii NW, Patel SG, Rhys-Evans PH, Breach NM. Management of the N0 neck in early cancer of the tongue. Clin Otolaryngol. 1999;24:75–9.

    Article  CAS  PubMed  Google Scholar 

  109. August M, Gianetti K. Elective neck irradiation versus observation of the clinically negative neck of patients with oral cancer. J Oral Maxillofac Surg. 1996;54:1050–5.

    Article  CAS  PubMed  Google Scholar 

  110. Keski-Säntti H, Atula T, Törnwall J, et al. Elective neck treatment versus observation in patients with T1/T2 N0 squamous cell carcinoma of the oral tongue. Oral Oncol. 2006;42:96–101.

    Article  PubMed  Google Scholar 

  111. McGuirt WF, Johnson JT, Myers EN, et al. Floor of mouth carcinoma; management of the clinically negative neck. Arch Otolaryngol Head Neck Surg. 1995;121:278–82.

    Article  PubMed  Google Scholar 

  112. Kligerman J, Lima RA, Soares JR, et al. Supraomohyoid neck dissection in the treatment of T1/T2 squamous cell carcinoma of oral cavity. Am J Surg. 1994;168:391–4.

    Article  CAS  PubMed  Google Scholar 

  113. Kowalski LP. Results of salvage treatment of the neck in patients with oral cancer. Arch Otolaryngol Head Neck Surg. 2002;128:58–62.

    Article  PubMed  Google Scholar 

  114. Fakih AR, Rao RS, Borges AM, et al. Elective versus therapeutic neck dissection n early carcinoma of the tongue. Am J Surg. 1989;158:309–13.

    Article  CAS  PubMed  Google Scholar 

  115. Vandenbrouck C, Sancho-Garnier H, Chassagen D, et al. Elective versus therapeutic neck dissection in epidermoid carcinoma of the oral cavity: results of a randomized clinical trial. Cancer. 1980;46:386–90.

    Article  CAS  PubMed  Google Scholar 

  116. Khafif A, Lopez-Garza JR, Medina JE. Is dissection of level IV necessary in patients with T1-T3N0 tongue cancer? Laryngoscope. 2001;111:1088–90.

    Article  CAS  PubMed  Google Scholar 

  117. Duvvuri U, Simental AA, D’Angelo G, et al. Elective neck dissection and survival in patients with squamous cell carcinoma of the oral cavity and oropharynx. Laryngoscope. 2004;114:2228–34.

    Article  PubMed  Google Scholar 

  118. Yuen AP, Ho CM, Chow TL, et al. Prospective randomized study of selective neck dissection versus observation for N0 neck of early tongue carcinoma. Head Neck. 2009;31:765–72.

    Article  PubMed  Google Scholar 

  119. D’Cruz AK, Siddachari RC, Walvekar RR, et al. Elective neck dissection for the management of the N0 neck in early cancer of the oral tongue: need for a randomized controlled trial. Head Neck. 2009;31:618–24.

    Article  PubMed  Google Scholar 

  120. Weiss MH, Harrison LB, Isaacs RS. Use of decision analysis in planning a management strategy for the stage N0 neck. Arch Otolaryngol Head Neck Surg. 1994;120:699–702.

    Article  CAS  PubMed  Google Scholar 

  121. Sparano A, Weinstein G, Chalian A, et al. Multivariate predictors of occult neck metastasis in early oral tongue cancer. Otolaryngol Head Neck Surg. 2004;131:472–6.

    Article  PubMed  Google Scholar 

  122. Kurokawa H, Yamashita Y, Takeda S, et al. Risk factors for late cervival lymph node metastases in patients with stage I and II carcinoma of the tongue. Head Neck. 2002;24:731–6.

    Article  PubMed  Google Scholar 

  123. Sheahan P, O’Keane C, Sheahan JN, et al. Effect of tumour thickness and other factors on the risk of regional disease and treatment of the N0 neck in early oral squamous cell carcinoma. Clin Otolaryngol. 2003;28:461–71.

    Article  CAS  PubMed  Google Scholar 

  124. Lim SC, Zhang S, Ishii G, et al. Predictive markers for late cervical metastasis in stage I and II invasive squamous cell carcinoma of the oral tongue. Clin Cancer Res. 2004;10:166–72.

    Article  CAS  PubMed  Google Scholar 

  125. Shingaki S, Suzuki, Nakajima T, et al. Evaluation of histopathological parameters in predicting cervical lymph node metastasis of oral and oropharyngeal carcinomas. Oral Surg Oral Med Oral Pathol. 1988;66:683–8.

    Article  CAS  PubMed  Google Scholar 

  126. Leusink FK, van Es RJ, de Bree R, et al. Novel diagnostic modalities for assessment of the clinically node-negative neck in oral squamous-cell carcinoma. Lancet Oncol. 2012;13:e554–61.

    Article  PubMed  Google Scholar 

  127. Borgmeester MC, van den Brekel MWM, van Tinteren H, et al. Ultrasound-guided aspiration cytology for the assessment of the clinically N0 neck: factors influencing its accuracy. Head Neck. 2008;30:1505–13.

    Article  Google Scholar 

  128. Nieuwenhuis EJ, Castelijns JA, Pijpers R, et al. Wait-and-see policy for the N0 neck in early-stage oral and oropharyngeal squamous cell carcinoma using ultrasonography-guided cytology: is there a role for identification of the sentinel node? Head Neck. 2002;24:282–9.

    Article  PubMed  Google Scholar 

  129. Flach GB, Tenhagen M, de Bree R, et al. Outcome of patients with early stage oral cancer managed by an observation strategy towards the N0 neck using ultrasound guided fine needle aspiration cytology: no survival difference as compared to elective neck dissection. Oral Oncol. 2013;49:157–64.

    Article  PubMed  Google Scholar 

  130. Mendenhall WM, Million RR, Cassisi NJ, et al. Elective neck irradiation in squamous-cell carcinoma of the head and neck. Head Neck Surg. 1980;3:15–20.

    Article  CAS  PubMed  Google Scholar 

  131. de Bree R, Takes RP, Castelijns JA, et al. Advances in diagnostic modalities to detect occult lymph node metastases in head and neck squamous cell carcinoma. Head Neck. 2015;37(12):1829–39.

    Article  PubMed  Google Scholar 

  132. de Bondt RBJ, Nelemans PJ, Hofman PAM, et al. Detection of lymph node metastases in head and neck cancer: a meta-analysis comparing US, USgFNAC, CT and MR imaging. Eur J Radiol. 2007;64:266–72.

    Article  PubMed  Google Scholar 

  133. Liao LJ, Lo WC, Hsu WL, et al. Detection of cervical lymph node metastasis in head and neck cancer patients with clinically N0 neck-a meta-analysis comparing different imaging modalities. BMC Cancer. 2012;12:236.

    Article  PubMed  PubMed Central  Google Scholar 

  134. Alkureishi LW, Burak Z, Alvarez JA, et al. Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma. Ann Surg Oncol. 2009;16:3190–210.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  135. Govers TM, Hannink G, Merkx MA, et al. Sentinel node biopsy for squamous cell carcinoma of the oral cavity and oropharynx: a diagnostic meta-analysis. Oral Oncol. 2013;49:726–32.

    Article  PubMed  Google Scholar 

  136. Werner JA, Dünne AA, Ramaswamy A, et al. Sentinel node detection in N0 cancer of the pharynx and larynx. Br J Cancer. 2002;87:711–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  137. Brizel DM, Prosnitz RG, Hunter S, et al. Necessity for adjuvant neck dissection in setting of concurrent chemotherapy for advanced head and neck cancer. Int J Radiat Oncol Biol Phys. 2004;58:1418–23.

    Article  PubMed  Google Scholar 

  138. Clark J, Li W, Smith G, Shannon K, et al. Outcome of treatment for advanced cervical metastatic squamous cell carcinoma. Head Neck. 2005;27:87–94.

    Article  PubMed  Google Scholar 

  139. Tselis N, Ratka M, Vogt HG, et al. Hypofractionated accelerated CT-guided interstitial 192Ir-HDR-Brachytherapy as re-irradiation in inoperable recurrent cervical lymphadenopathy from head and neck cancer. Radiother Oncol. 2011;98:57–62.

    Article  PubMed  Google Scholar 

  140. Van Wilgen CP, Dijkstra PU, Van der Laan BFAM, et al. Shoulder and neck morbidity in quality of life after surgery for head and neck cancer. Head Neck. 2004;26:839–44.

    Article  PubMed  Google Scholar 

  141. Rogers SN, Ferlito A, Pellitteri PK, et al. Quality of life following neck dissections. Acta Otolaryngol. 2004;124:231–16.

    Article  PubMed  Google Scholar 

  142. Van Wilgen CP, Dijkstra PU, Van der Laan BFAM, et al. Morbidity of the neck after head and neck cancer therapy. Head Neck. 2004;26:785–91.

    Article  PubMed  Google Scholar 

  143. Boca E. Functional neck dissection: an evaluation and review of 843 cases. Laryngoscope. 1984;94:942–5.

    Google Scholar 

  144. Remmler D, Byers R, Scheetz J. A study of shoulder disability resulting from radical and modified neck dissections. Head Neck Surg. 1986;8:280–6.

    Article  CAS  PubMed  Google Scholar 

  145. El Ghani F, van den Brekel MWM, de Goede CJT, et al. Shoulder function and patient well-being after various types of neck dissections. Clin Otolaryngol. 2002;27:403–8.

    Article  PubMed  Google Scholar 

  146. Erisen L, Basel B, Irdesei J, et al. Shoulder function after accessory nerve-sparing neck dissections. Head Neck. 2004;26:967–71.

    Article  PubMed  Google Scholar 

  147. Medina J. Supraomohyoid neck dissection: rational, indications and surgical technique. Head Neck. 1989;11:111–22.

    Article  CAS  PubMed  Google Scholar 

  148. van Wouwe M, de Bree R, Kuik DJ, et al. Shoulder morbidity after non-surgical treatment of the neck. Radiother Oncol. 2009;90:296–01.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Head and Neck Surgery, UMC Utrecht Cancer Center, Heidelberglaan 100, Utrecht, 3584 CX, The Netherlands

    Remco de Bree MD, PhD

  2. Department of Radiation Oncology, University Medical Center Groningen, Groningen, The Netherlands

    Johannes A. Langendijk MD, PhD

  3. Department of Otolaryngology, Head and Neck Surgery, VU University Medical Center, Amsterdam, The Netherlands

    C. R. Leemans MD, PhD

Authors
  1. Remco de Bree MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Johannes A. Langendijk MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. R. Leemans MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Remco de Bree MD, PhD .

Editor information

Editors and Affiliations

  1. Department of Radio-Oncology, Genolier Swiss Medical Network, Genolier, Switzerland

    Jacques Bernier

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

de Bree, R., Langendijk, J.A., Leemans, C.R. (2016). Multidisciplinary Treatment of the Neck. In: Bernier, J. (eds) Head and Neck Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-27601-4_33

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-27601-4_33

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-27599-4

  • Online ISBN: 978-3-319-27601-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation